Related Experiment Video
Updated: Apr 15, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[What's new in rectal cancer?]
Multidisciplinary rectal cancer treatment, including total mesorectal excision (TME) surgery and chemoradiotherapy, has improved patient outcomes. While TME reduces recurrence, further research is needed to enhance survival rates for advanced tumors.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Context:
- Rectal cancer management has evolved with multidisciplinary approaches.
- Progress in surgical techniques and neoadjuvant therapies is notable.
- Focus on locoregional control within the mesorectum is critical.
Purpose:
- To review advancements in rectal cancer therapeutic strategies.
- To highlight progress in surgical techniques, particularly total mesorectal excision (TME).
- To discuss the role of chemoradiotherapy in rectal cancer treatment.
Summary:
- Multidisciplinary treatment is standard for rectal cancer.
- Total mesorectal excision (TME) surgery reduces local recurrence and genitourinary issues.
- Chemoradiotherapy is increasingly important, especially for T3/T4 N+ tumors, to decrease local recurrence.
Impact:
- Advances in imaging and therapeutic modalities have improved rectal cancer prognosis.
- Total mesorectal excision (TME) has significantly impacted local recurrence rates.
- Ongoing research aims to further improve survival outcomes for rectal cancer patients.
More Related Videos
04:09The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors
Published on: February 13, 2026
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
